Viewing Study NCT00002033


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2026-05-05 @ 3:13 AM
Study NCT ID: NCT00002033
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acquired Immunodeficiency Syndrome View
None AIDS-Related Complex View
None ammonium trichloro(dioxoethylene-O,O'-)tellurute View
None Zidovudine View